Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy for Pancreatic Cancer: GS vs. GnP
NCT05268692Phase 3Recruiting
- Sponsor
- Kochi University
- Start
- Jan 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur, paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by Kochi University. Started Jan 2019; status: recruiting.
02
Drugs
tegafurpaclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT05268692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05268692.